Precursors of glutamate (Gln) Gln acts as a precursor of glutamate (Glu), equivalent to being an indirect glutathione precursor
European Union: Subject to Novel Food authorization
B: Peginterferon alfa-2b, 1 g/kg subcutaneously once weekly, or Peginterferon alfa-2a, 135 g subcutaneously once weekly plus Ribavirin, 200800 mg/day in two divided does starting with low dose and increasing gradually C: Controversial: Standard interferon (2a or 2b) 3mU three times weekly, or Pegylated interferon alfa-2b, 1 g/kg/week, or Pegylated interferon alfa-2a, 135 g/kg/week Ribavirin in markedly reduced daily dose
Only New Zealand and, despite the decade-long opposition of the American Medical Association, the United States allow direct-to-consumer prescription drug advertising. To view or add a comment, sign in A cautionary note for digital health and life sciences companies
The study is published in Nature Medicine.